![](/img/cover-not-exists.png)
19 Cost-effectiveness of adding zoledronic acid to endocrine therapy in premenopausal women with hormone-responsive early breast cancer in Portugal, Spain, and Italy, based on the ABCSG-12 Study
T.E. Delea, C. Tanaja, S. Kaura, P. Sternini, S. Gerzeli, M. GnantVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70051-3
File:
PDF, 67 KB
english, 2010